BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 12843452)

  • 1. A PCR-based method for studying DNA methylation.
    Ariel M
    Methods Mol Biol; 2001; 181():205-16. PubMed ID: 12843452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation of multiple promoter-associated CpG islands in adult acute lymphocytic leukemia.
    Garcia-Manero G; Daniel J; Smith TL; Kornblau SM; Lee MS; Kantarjian HM; Issa JP
    Clin Cancer Res; 2002 Jul; 8(7):2217-24. PubMed ID: 12114423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation-specific PCR.
    Ku JL; Jeon YK; Park JG
    Methods Mol Biol; 2011; 791():23-32. PubMed ID: 21913069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between methylation profile of promoter cpg islands of seven metastasis-associated genes and their expression states in six cell lines of liver origin.
    Li JL; Fei Q; Yu J; Zhang HY; Wang P; Zhu JD
    Ai Zheng; 2004 Sep; 23(9):985-91. PubMed ID: 15363188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylation and chromatin structure: the puzzling CpG islands.
    Caiafa P; Zampieri M
    J Cell Biochem; 2005 Feb; 94(2):257-65. PubMed ID: 15546139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia.
    Gebhard C; Schwarzfischer L; Pham TH; Schilling E; Klug M; Andreesen R; Rehli M
    Cancer Res; 2006 Jun; 66(12):6118-28. PubMed ID: 16778185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CpG methylation inactivates the transcriptional activity of the promoter of the human p53 tumor suppressor gene.
    Schroeder M; Mass MJ
    Biochem Biophys Res Commun; 1997 Jun; 235(2):403-6. PubMed ID: 9199206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on the methylation of p15 gene CpG islands in acute leukemia: using methylation-specific PCR method].
    Zhang Y; Lou F; Yu L
    Zhonghua Xue Ye Xue Za Zhi; 1999 Dec; 20(12):628-30. PubMed ID: 11721363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoter CpG methylation of tumor suppressor genes in colorectal cancer and its relationship to clinical features.
    Lin SY; Yeh KT; Chen WT; Chen HC; Chen ST; Chiou HY; Chang JG
    Oncol Rep; 2004 Feb; 11(2):341-8. PubMed ID: 14719065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation patterns of the human beta-glucuronidase gene locus: boundaries of methylation and general implications for frequent point mutations at CpG dinucleotides.
    Tomatsu S; Orii KO; Islam MR; Shah GN; Grubb JH; Sukegawa K; Suzuki Y; Orii T; Kondo N; Sly WS
    Genomics; 2002 Mar; 79(3):363-75. PubMed ID: 11863366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [CpG island methylation of E-cadherin gene promoter in gastric carcinoma].
    Zhou YN; Xu CP; Han B; Ji R
    Ai Zheng; 2005 Oct; 24(10):1220-4. PubMed ID: 16219136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid and sensitive detection of CpG-methylation using methyl-binding (MB)-PCR.
    Gebhard C; Schwarzfischer L; Pham TH; Andreesen R; Mackensen A; Rehli M
    Nucleic Acids Res; 2006 Jul; 34(11):e82. PubMed ID: 16822855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Profile of methylation of certain tumor growth suppressing genes in non-small cell lung cancer].
    Zemliakova VV; Zhevlova AI; Zborovskaia IB; Strel'nikov VV; Laktionov KK; Zaletaev DV; Nemtsova MV
    Mol Biol (Mosk); 2003; 37(6):983-8. PubMed ID: 14714493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comprehensive analysis of allelic methylation status of CpG islands on human chromosome 21q.
    Yamada Y; Watanabe H; Miura F; Soejima H; Uchiyama M; Iwasaka T; Mukai T; Sakaki Y; Ito T
    Genome Res; 2004 Feb; 14(2):247-66. PubMed ID: 14762061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of promoter polymorphism of nuclear factor-erythroid 2-related factor 2 gene on the aberrant DNA methylation in gastric epithelium.
    Arisawa T; Tahara T; Shibata T; Nagasaka M; Nakamura M; Kamiya Y; Fujita H; Yoshioka D; Arima Y; Okubo M; Hirata I; Nakano H
    Oncol Rep; 2008 Jan; 19(1):211-6. PubMed ID: 18097597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome.
    Weber M; Hellmann I; Stadler MB; Ramos L; Pääbo S; Rebhan M; Schübeler D
    Nat Genet; 2007 Apr; 39(4):457-66. PubMed ID: 17334365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CpG island methylator phenotype correlates with long-range epigenetic silencing in colorectal cancer.
    Karpinski P; Ramsey D; Grzebieniak Z; Sasiadek MM; Blin N
    Mol Cancer Res; 2008 Apr; 6(4):585-91. PubMed ID: 18403637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-CpG cytosine methylation of p53 exon 5 in non-small cell lung carcinoma.
    Kouidou S; Agidou T; Kyrkou A; Andreou A; Katopodi T; Georgiou E; Krikelis D; Dimitriadou A; Spanos P; Tsilikas C; Destouni H; Tzimagiorgis G
    Lung Cancer; 2005 Dec; 50(3):299-307. PubMed ID: 16125822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tandem repeats in the CpG islands of imprinted genes.
    Hutter B; Helms V; Paulsen M
    Genomics; 2006 Sep; 88(3):323-32. PubMed ID: 16690248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methylation of multiple promoter-associated CpG islands in meningiomas: relationship with the allelic status at 1p and 22q.
    Bello MJ; Amiñoso C; Lopez-Marin I; Arjona D; Gonzalez-Gomez P; Alonso ME; Lomas J; de Campos JM; Kusak ME; Vaquero J; Isla A; Gutierrez M; Sarasa JL; Rey JA
    Acta Neuropathol; 2004 Nov; 108(5):413-21. PubMed ID: 15365725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.